Literature DB >> 9310367

Efficiency of P-glycoprotein-mediated exclusion of rhodamine dyes from multidrug-resistant cells is determined by their passive transmembrane movement rate.

G D Eytan1, R Regev, G Oren, C D Hurwitz, Y G Assaraf.   

Abstract

The aim of the present study was to examine the relationship between the rate of the passive transmembrane movement of multidrug resistance (MDR)-type substrates and the ability of P-glycoprotein to extrude them from MDR cells. For this purpose, seven rhodamine dyes were examined for their P-glycoprotein-mediated exclusion from MDR cells, their localization in wild-type drug-sensitive cells, their capacity to stimulate the ATPase activity of P-glycoprotein reconstituted in proteoliposomes, and their transmembrane movement rate in artificial liposomes. All these rhodamine dyes were accumulated in wild-type drug-sensitive cells and were localized mainly in the mitochondria. All the dyes tested were substrates of reconstituted P-glycoprotein and cellular P-glycoprotein and were excluded to a variable degree from MDR cells. The transmembrane movement rate proved the major factor determining the efficacy of the P-glycoprotein-mediated exclusion of rhodamine dyes from MDR cells. Thus, rhodamine B, the poorest cellular P-glycoprotein substrate, exhibited a high affinity toward reconstituted P-glycoprotein, but was the fastest membrane-traversing dye. In contrast, tetramethylrosamine, the best cellular MDR probe, exhibited high affinity toward reconstituted P-glycoprotein and slow transmembrane movement rate. Therefore, an anticancer drug with a fast transmembrane movement rate is expected to overcome the MDR phenomenon. Furthermore, the widely used MDR marker, rhodamine 123, was a poor cellular MDR substrate compared with other rhodamine dyes, especially tetramethylrosamine, which was a superior cellular MDR substrate for functional dye-exclusion studies.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9310367     DOI: 10.1111/j.1432-1033.1997.00104.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  29 in total

1.  Thiorhodamines containing amide and thioamide functionality as inhibitors of the ATP-binding cassette drug transporter P-glycoprotein (ABCB1).

Authors:  Alexandra Orchard; Gregory A Schamerhorn; Brandon D Calitree; Geri A Sawada; Tip W Loo; M Claire Bartlett; David M Clarke; Michael R Detty
Journal:  Bioorg Med Chem       Date:  2012-06-07       Impact factor: 3.641

Review 2.  On a biophysical and mathematical model of Pgp-mediated multidrug resistance: understanding the "space-time" dimension of MDR.

Authors:  Vasiliki Panagiotopoulou; Giles Richardson; Oliver E Jensen; Cyril Rauch
Journal:  Eur Biophys J       Date:  2009-11-04       Impact factor: 1.733

3.  Influence of passive permeability on apparent P-glycoprotein kinetics.

Authors:  K A Lentz; J W Polli; S A Wring; J E Humphreys; J E Polli
Journal:  Pharm Res       Date:  2000-12       Impact factor: 4.200

4.  Export pumps in Epulopiscium fishelsoni, the symbiotic giant gut bacterium in Acanthurus nigrofuscus.

Authors:  V Bresler; L Fishelson
Journal:  Naturwissenschaften       Date:  2006-03-14

5.  Evidence for modulation of P-glycoprotein-mediated efflux by methoxypolyethylene glycol-block-Polycaprolactone amphiphilic diblock copolymers.

Authors:  Jason Zastre; John Jackson; Helen Burt
Journal:  Pharm Res       Date:  2004-08       Impact factor: 4.200

6.  Rhodamine inhibitors of P-glycoprotein: an amide/thioamide "switch" for ATPase activity.

Authors:  Michael K Gannon; Jason J Holt; Stephanie M Bennett; Bryan R Wetzel; Tip W Loo; M Claire Bartlett; David M Clarke; Geri A Sawada; J William Higgins; Gregory Tombline; Thomas J Raub; Michael R Detty
Journal:  J Med Chem       Date:  2009-05-28       Impact factor: 7.446

7.  Characterization and evaluation of 5-fluorouracil-loaded solid lipid nanoparticles prepared via a temperature-modulated solidification technique.

Authors:  Meghavi N Patel; Sushant Lakkadwala; Mohamed S Majrad; Elisha R Injeti; Steven M Gollmer; Zahoor A Shah; Sai Hanuman Sagar Boddu; Jerry Nesamony
Journal:  AAPS PharmSciTech       Date:  2014-07-18       Impact factor: 3.246

8.  Kinetic analysis of rhodamines efflux mediated by the multidrug resistance protein (MRP1).

Authors:  Chantarawan Saengkhae; Chatchanok Loetchutinat; Arlette Garnier-Suillerot
Journal:  Biophys J       Date:  2003-09       Impact factor: 4.033

9.  Midazolam exhibits characteristics of a highly permeable P-glycoprotein substrate.

Authors:  Sanna Tolle-Sander; Jarkko Rautio; Steve Wring; Joseph W Polli; James E Polli
Journal:  Pharm Res       Date:  2003-05       Impact factor: 4.200

10.  Cost, effectiveness and environmental relevance of multidrug transporters in sea urchin embryos.

Authors:  Bryan J Cole; Amro Hamdoun; David Epel
Journal:  J Exp Biol       Date:  2013-08-02       Impact factor: 3.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.